These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19996413)

  • 21. Factor XIII: Structure and Function.
    Schroeder V; Kohler HP
    Semin Thromb Hemost; 2016 Jun; 42(4):422-8. PubMed ID: 27019464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional factor XIII-A is exposed on the stimulated platelet surface.
    Mitchell JL; Lionikiene AS; Fraser SR; Whyte CS; Booth NA; Mutch NJ
    Blood; 2014 Dec; 124(26):3982-90. PubMed ID: 25331118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor XIII and venous thromboembolism.
    Bereczky Z; Muszbek L
    Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration.
    Byrnes JR; Lee T; Sharaby S; Campbell RA; Dobson DA; Holle LA; Luo M; Kangro K; Homeister JW; Aleman MM; Luyendyk JP; Kerlin BA; Dumond JB; Wolberg AS
    Blood; 2024 Feb; 143(5):444-455. PubMed ID: 37883802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XIII activity mediates red blood cell retention in venous thrombi.
    Aleman MM; Byrnes JR; Wang JG; Tran R; Lam WA; Di Paola J; Mackman N; Degen JL; Flick MJ; Wolberg AS
    J Clin Invest; 2014 Aug; 124(8):3590-600. PubMed ID: 24983320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acquired autoimmune coagulation factor XIII/13 deficiency].
    Ogawa Y
    Rinsho Ketsueki; 2020; 61(7):799-808. PubMed ID: 32759568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability.
    Mitchell JL; Little G; Bye AP; Gaspar RS; Unsworth AJ; Kriek N; Sage T; Stainer A; Sangowawa I; Morrow GB; Bastos RN; Shapiro S; Desborough MJR; Curry N; Gibbins JM; Whyte CS; Mutch NJ; Jones CI
    Res Pract Thromb Haemost; 2023 Jul; 7(5):100200. PubMed ID: 37601014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
    Lovejoy AE; Reynolds TC; Visich JE; Butine MD; Young G; Belvedere MA; Blain RC; Pederson SM; Ishak LM; Nugent DJ
    Blood; 2006 Jul; 108(1):57-62. PubMed ID: 16556896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
    Cordell PA; Newell LM; Standeven KF; Adamson PJ; Simpson KR; Smith KA; Jackson CL; Grant PJ; Pease RJ
    Matrix Biol; 2015 Apr; 43():85-96. PubMed ID: 25680676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor XIII Deficiency.
    Karimi M; Bereczky Z; Cohan N; Muszbek L
    Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factor XIII in man: a review].
    Dufner GS; Marbet GA
    Hamostaseologie; 2002 Feb; 22(1):11-9. PubMed ID: 12193980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice.
    Kattula S; Byrnes JR; Martin SM; Holle LA; Cooley BC; Flick MJ; Wolberg AS
    Blood Adv; 2018 Jan; 2(1):25-35. PubMed ID: 29344582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages.
    Töröcsik D; Szeles L; Paragh G; Rakosy Z; Bardos H; Nagy L; Balazs M; Inbal A; Adány R
    Thromb Haemost; 2010 Oct; 104(4):709-17. PubMed ID: 20664907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
    Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
    Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Factor XIII.
    Muszbek L; Katona É; Kerényi A
    Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of amino acid residues that are crucial for FXIII-A intersubunit interactions and stability.
    Li B; Kohler HP; Schroeder V
    Blood; 2020 Jan; 135(2):145-152. PubMed ID: 31697820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the pro-angiogenic effect of factor XIII in heterotopic mouse heart allografts and FXIII-deficient mice.
    Dardik R; Leor J; Skutelsky E; Castel D; Holbova R; Schiby G; Shaish A; Dickneite G; Loscalzo J; Inbal A
    Thromb Haemost; 2006 Mar; 95(3):546-50. PubMed ID: 16525585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
    Souri M; Osaki T; Ichinose A
    J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.